Changes in the normal maximal expiratory flow-volume curve with growth and aging.
about
Low bone mineral density in adults with cystic fibrosisInhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic FibrosisThe World Trade Center disaster and the health of workers: five-year assessment of a unique medical screening programMeasurements of respiratory illness among construction paintersLung cancer in a nonsmoking underground uranium minerAssociation between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezingReference ranges for spirometry across all ages: a new approachThe Mexican response to high altitudes in the 1890s: the case of a physician and his "magic mountain".Influence of ACE-inhibition on salt-mediated worsening of pulmonary gas exchange in heart failureLung function in our aging populationEthnic differences in the prevalence of nonmalignant respiratory disease among uranium minersMulti-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equationsLongitudinal Lung Function Decrease in Subjects with Spontaneous Healed Pulmonary TuberculosisLung function in asbestos-exposed workers, a systematic review and meta-analysisTime for new reference values for ventilatory lung functionRecommendations for using standardised phenotypes in genetic association studiesLong-term follow-up of beryllium sensitized workers from a single employerRespiratory involvements among women exposed to the smoke of traditional biomass fuel and gas fuel in a district of BangladeshEvaluation of physical health effects due to volcanic hazards: human studiesDo waste incinerators induce adverse respiratory effects? An air quality and epidemiological study of six communitiesLung injury induced by secondhand smoke exposure detected with hyperpolarized helium-3 diffusion MR.Evaluation of a novel technique in airway clearance therapy - Specific Cough Technique (SCT) in cystic fibrosis: A pilot study of a series of N-of-1 randomised controlled trials.Asthma outcomes: pulmonary physiology.Assessment of the lung microstructure in patients with asthma using hyperpolarized 3He diffusion MRI at two time scales: comparison with healthy subjects and patients with COPD.Helium-3 diffusion MR imaging of the human lung over multiple time scales.Heritability of lung disease severity in cystic fibrosis.EPIDEMIOLOGY OF AGE-DEPENDENCE IN SLEEP DISORDERED BREATHING (SDB) IN OLD AGE: THE BAY AREA SLEEP COHORT (BASC).Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.Primary ciliary dyskinesia: evaluation using cilia beat frequency assessment via spectral analysis of digital microscopy images.Cardio-respiratory reference data in 4631 healthy men and women 20-90 years: the HUNT 3 fitness study.How Reliable Are Current Data for Assessing the Actual Prevalence of Chronic Obstructive Pulmonary Disease?Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function dataInflammatory related changes in bone mineral content in adults with cystic fibrosisSoftware for interpreting cardiopulmonary exercise tests.Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era.Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain.Lung function abnormalities in repaired oesophageal atresia and tracheo-oesophageal fistula.Respiratory effects of exposure of shipyard workers to epoxy paintsEfficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosisClinical experience and results of a Sentinel Health Investigation related to indoor fungal exposure.
P2860
Q22299322-7FC28661-F9F2-44AD-A2A9-1B93C35C1660Q22306312-0A3FDAB6-13C0-45B4-9709-89F946E1C243Q23920402-EA5549D1-D53C-434E-BAF5-FE7061485B7DQ23922650-D29CC45C-6960-4FEE-90AF-39BEACDA3300Q24536696-B52F0E87-F7AB-4805-A4DB-C60C19CF2BCCQ24561362-F0A94632-35BD-47DF-90B3-2B76B8E37447Q24652803-B331B126-DD3A-49BF-AF74-DC6DFF0BE048Q24793588-798C1826-B010-45AA-95D3-BA9FE1BEF3E2Q28367541-F523EA12-630B-4DEF-A777-FE17B9233A63Q28384406-D069C09C-2624-4500-A14C-50E4D33947ECQ28387583-B7C0A0C8-3B22-433B-9C68-B848B1E9166BQ28389258-8A0D5E28-198E-49B1-83A2-BF77F58C9617Q28390954-D10F7F9A-52A0-49D6-B8B5-7F5844E1D89AQ28391439-DEB4B13A-5E18-4C0A-B382-058AE5D72A18Q28391976-E7356603-CBC0-4724-BCBE-9840CC850146Q28392134-901228F0-AA2A-47C8-8659-1F2D425CDD05Q28393685-5BBA9C1F-C1BB-4DA9-BD07-BE652BCE7F96Q28658156-27C18DC5-AA31-42F4-B4FB-FB7556ACFF5EQ28766490-3E30CC05-C1C9-4043-87CA-124FCF0FC10EQ28768272-F6F187A6-F87F-4FE7-9ADA-93E7BEC43AD1Q30355822-B67E6E2E-C4ED-4942-82C2-772260F932BDQ30355880-89C0E5E2-E7A4-4EB2-AFE7-61118767B981Q30423167-79A61DA4-4691-4A7D-BD7E-A3331B0A4212Q30436829-D19DDDB8-2A05-4EC4-BD1F-0F92E17BB37FQ30439503-E92E1DDE-144C-461A-BCB4-99D97FEE9522Q30441770-7D1E3799-0918-4E71-8B3A-9F9ED66AB3C0Q30483060-D514B460-1C95-4CDE-AD5D-8F4D663C22E6Q30494108-FB1BAA34-7324-4976-9FD6-A6B5CE0074EAQ30502506-41F0FF43-BC1E-418E-A48A-C2CC898D6A7FQ30872120-6FBDF86F-34ED-457B-B146-2B6A6233A0F9Q31048179-F9FAA819-EFF8-4FC7-AED1-681B547A955EQ31049430-121B1FFA-A6E7-4705-82F0-D5BBA6220801Q33204318-82C0D853-2104-46FA-A778-E5722F6B74FEQ33303497-CB516A7E-7FD4-4797-BCD9-0EEC70FE4C1AQ33484755-C22B7187-A674-449F-8C5B-5E385F8D5EF2Q33602084-C8913479-B0F7-4465-A103-9D3D42AF0B56Q33604597-3BBF0A22-328B-4179-AD71-134340D7C0CEQ33634651-EAE4B166-81CE-4CD4-9E31-82705C57AF45Q33637615-056FCA6B-B811-4C98-B27A-5E2A8839008EQ33646229-37FEBCA8-9C1B-4773-8571-3E40C4347757
P2860
Changes in the normal maximal expiratory flow-volume curve with growth and aging.
description
1983 nî lūn-bûn
@nan
1983 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Changes in the normal maximal expiratory flow-volume curve with growth and aging.
@ast
Changes in the normal maximal expiratory flow-volume curve with growth and aging.
@en
Changes in the normal maximal expiratory flow-volume curve with growth and aging.
@nl
type
label
Changes in the normal maximal expiratory flow-volume curve with growth and aging.
@ast
Changes in the normal maximal expiratory flow-volume curve with growth and aging.
@en
Changes in the normal maximal expiratory flow-volume curve with growth and aging.
@nl
prefLabel
Changes in the normal maximal expiratory flow-volume curve with growth and aging.
@ast
Changes in the normal maximal expiratory flow-volume curve with growth and aging.
@en
Changes in the normal maximal expiratory flow-volume curve with growth and aging.
@nl
P2093
P1476
Changes in the normal maximal expiratory flow-volume curve with growth and aging.
@en
P2093
Holberg CJ
Knudson RJ
Lebowitz MD
P304
P356
10.1164/ARRD.1983.127.6.725
P577
1983-06-01T00:00:00Z